Neratinib in HER2-Positive Breast Cancer Patients.
Paranjpe R, Basatneh D, Tao G, De Angelis C, Noormohammed S, Ekinci E, Abughosh S, Ghose R, Trivedi MV.
Paranjpe R, et al. Among authors: ekinci e.
Ann Pharmacother. 2019 Jun;53(6):612-620. doi: 10.1177/1060028018824088. Epub 2019 Jan 4.
Ann Pharmacother. 2019.
PMID: 30607980